Anecortave

Embed this Topic
Anecortave (rINN) (pronounced /ænəˈkɔrteɪv/) is a novel angiogenesis inhibitor used in the treatment of the exudative (wet) form of age-related macular degeneration. Although based on a steroid nucleus, it possesses little glucocorticoid activity. It will be marketed by Alcon as anecortave acetate for depot suspension under the trade name Retaane.
Read article at Wikipedia

Medicine

ATC Code:

  • S01XA16

Pubchem:

  • 111,332

CAS Number:

  • 7753-60-8

Route of administration:

top ↑

We can also tell you Anecortave is a…

If you know more about Anecortave, you can add more facts here »

These people have edited this topic:

  • jg Metaweb Staff
Edit this topic
Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!

Freebase Attribution

Freebase data is free for use under the CC-BY license.

The original description for Anecortave was automatically generated from Wikipedia.org licensed under the GNU Free Documentation License.
[1]
Learn more about Freebase licensing and attribution